FUJIFILM Diosynth Biotechnologies

Research Triangle, NC · Holly Springs, NC · Hillerod, DK
AAV mRNA
Program data pending ClinicalTrials.gov matching · Last scored 2026-03-15
69.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (1)

Quick Facts: FUJIFILM Diosynth Biotechnologies

Signal Score
69.0/100 (as of 2026-03-15)
Quality Compliance
Assessment pending
Headquarters
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Modalities
AAV, mRNA
Active CGT Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CGT manufacturing intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, mRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 75.0
Strong parent backing: FUJIFILM Holdings (Japan)
Source: SEC EDGAR, press monitoring
Subsidiary of FUJIFILM Holdings
SEC FilingsParent: FUJIFILM Holdings
Strong parent backing: FUJIFILM Holdings (Japan)
Capacity 63.0
3 CGT manufacturing sites
Sites: Research Triangle Park, NC, Hillerød, Denmark, Holly Springs, NC
Source: SEC EDGAR, press monitoring, company profiles
3 CGT manufacturing sites
StatusExpanding
3 CGT manufacturing sites
Sites: Research Triangle Park, NC, Hillerød, Denmark, Holly Springs, NC
Recent Press1 articles
3 CGT manufacturing sites

Recent News 1 articles

general 2026-03-19
Viral Vector Manufacturing Market Trends: Biologics Innovation & Forecast to 2033 - vocal.media
Viral Vector Manufacturing Market Trends: Biologics Innovation & Forecast to 2033  vocal.media
Source →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → mRNA CDMOs →